|
|
 |
Home |
|
|
|
About |
|
company history achievements our team |
|
Products |
|
|
|
Research |
|
|
|
Markets |
|
|
|
Contact |
|
|
|
News |
|
|
|
Publications |
|
|
| Management/Board of Directors |
| Dr. William E. Fahl Founder, Chairman, and Chief Scientific Officer |
| Dr. Paul M. Weiss, Managing Director, Venture Investors Acting President and CEO, Director |
| Dr. Allen L. Thunberg Vice President-Development |
| Todd G. Argall, C.P.A. Vice President-Finance |
| Loren G. Peterson, C.P.A., Managing Director, Venture Investors Director |
| Dr. Campbell Murray, Managing Director, Novartis Venture Fund Director |
| Robert Lippert, M.B.A., Former President and CEO, ZARS, Inc. Director |
| Joseph V. Gulfo, M.D., M.B.A., President and CEO, MELA Sciences, Inc. Director |
Scientific Advisory Board |
| Richard R. Copp, PhD. |
| Marylin Dodd, R.N., Ph.D. |
| Dorothy M.K. Keefe, M.D., FRACP |
| Minesh Mehta, M.D. |
| John Niederhuber, M.D. |
| Richard Okerholm, Ph.D. |
| Carl Porter, Ph.D. |
| Stephen T. Sonis, D.M.D., D.M.Sc. |
| Norman D. Weiner, Ph.D. |